Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Solo Brands, Inc. to Present and Host 1x1 Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 11, 2026
Solo Brands, Inc. (SBDS) Q1 2026 Earnings Call Transcript
Solo Brands, Inc. Announces Fiscal 2026 First Quarter Results
Solo Brands, Inc. Fiscal 2026 First Quarter Results To Be Released Thursday, May 14, 2026
NYSE to Commence Delisting Proceedings Against Solo Brands, Inc. (SBDS)
Solo Stove Partners with Rice Krispies Treats to Redefine Summer's Ultimate Roasting Experience
Solo Brands, Inc. Issues Fiscal Year 2026 Financial Guidance
Solo Brands, Inc. (SBDS) Q4 2025 Earnings Call Transcript
Solo Brands Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Solo Brands, Inc. Announces Fiscal 2025 Fourth Quarter and Full Year Results
Solo Brands, Inc. to Host 1x1 Meetings at the 38th Annual Roth Conference on March 23-24, 2026
Canacol Energy Announces Leadership Change and Independent Director Appointment
Chubbies Announces the Launch of Cheekies, Its New Women's Swim Brand
Solo Stove "Squashes the Beef at the Big Game," Turning Rivalries into Connection Over Fire and Food
Solo Brands, Inc. Provides Commentary on Preliminary Fiscal 2025 Fourth Quarter Results and Timing of its Full Year and Fourth Quarter Fiscal 2025 Financial Results and Conference Call
Solo Brands, Inc. Announces Corporate Simplification to Establish a Single Class of Common Stock and Limit Its Tax Receivable Agreement
Nike to report Q2 earnings amid weak DTC trends, mixed sentiment
Metalsource Mining Announces Eligibility for Depository Trust Company (DTC) Services
Defence Therapeutics Announces Formation of Scientific Advisory Board to Guide Advancement of Accum-Enhanced Antibody Drug Conjugate Programs
Defence Therapeutics Announces Convertible Debenture Conversion